XML 33 R21.htm IDEA: XBRL DOCUMENT
v3.25.3

Revenue Recognition (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Revenue Recognition [Abstract] |
Schedule of Disaggregated Revenue |
Net Sales by Business |  |  |  |  |  |  |
| Three Months |  | Nine Months
| 2025 |  | 2024 |  | 2025 |  | 2024
MedSurg and Neurotechnology: |  |  |  |  |  |  |
Instruments | $760 |  | $679 |  | $2,258 |  | $2,044
Endoscopy | 896 |  | 837 |  | 2,662 |  | 2,383
Medical | 985 |  | 938 |  | 2,920 |  | 2,710
Vascular | 525 |  | 329 |  | 1,429 |  | 966
Neuro Cranial | 637 |  | 541 |  | 1,816 |  | 1,533
| $3,803 |  | $3,324 |  | $11,085 |  | $9,636
Orthopaedics: |  |  |  |  |  |  |
Knees | $628 |  | $570 |  | $1,907 |  | $1,760
Hips | 457 |  | 420 |  | 1,366 |  | 1,241
Trauma and Extremities | 960 |  | 849 |  | 2,862 |  | 2,511
Spinal Implants | 6 |  | 172 |  | 177 |  | 521
Other | 203 |  | 159 |  | 548 |  | 490
| $2,254 |  | $2,170 |  | $6,860 |  | $6,523
Total | $6,057 |  | $5,494 |  | $17,945 |  | $16,159
Net Sales by Geography |  |  |  |  |
| Three Months 2025 |  | Three Months 2024
| United States | International |  | United States | International
MedSurg and Neurotechnology: |  |  |  |  |
Instruments | $606 | $154 |  | $544 | $135
Endoscopy | 743 | 153 |  | 689 | 148
Medical | 827 | 158 |  | 783 | 155
Vascular | 283 | 242 |  | 121 | 208
Neuro Cranial | 524 | 113 |  | 448 | 93
| $2,983 | $820 |  | $2,585 | $739
Orthopaedics: |  |  |  |  |
Knees | $452 | $176 |  | $417 | $153
Hips | 279 | 178 |  | 256 | 164
Trauma and Extremities | 703 | 257 |  | 621 | 228
Spinal Implants | — | 6 |  | 119 | 53
Other | 154 | 49 |  | 111 | 48
| $1,588 | $666 |  | $1,524 | $646
Total | $4,571 | $1,486 |  | $4,109 | $1,385
Net Sales by Geography |  |  |  |  |
| Nine Months 2025 |  | Nine Months 2024
| United States | International |  | United States | International
MedSurg and Neurotechnology: |  |  |  |  |
Instruments | $1,814 | $444 |  | $1,640 | $404
Endoscopy | 2,195 | 467 |  | 1,948 | 435
Medical | 2,469 | 451 |  | 2,261 | 449
Vascular | 754 | 675 |  | 369 | 597
Neuro Cranial | 1,496 | 320 |  | 1,255 | 278
| $8,728 | $2,357 |  | $7,473 | $2,163
Orthopaedics: |  |  |  |  |
Knees | $1,376 | $531 |  | $1,279 | $481
Hips | 831 | 535 |  | 768 | 473
Trauma and Extremities | 2,118 | 744 |  | 1,842 | 669
Spinal Implants | 118 | 59 |  | 361 | 160
Other | 394 | 154 |  | 347 | 143
| $4,837 | $2,023 |  | $4,597 | $1,926
Total | $13,565 | $4,380 |  | $12,070 | $4,089
Contract with Customer, Contract Asset, Contract Liability, and Receivable | Changes in contract liabilities during the nine months 2025 were as follows:
| September 30
| 2025
Beginning contract liabilities | $978
Revenue recognized from beginning of year contract liabilities | (492)
Net advance consideration received during the period | 453
Ending contract liabilities | $939

X
- Definition Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10 + Details
Name: | us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueRecognitionAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration